MedMen Capital pursues strategic investments in large addressable markets that are supply-constrained and have high barriers to entry.

It operates through a series of investment funds that capitalize on MedMen’s expertise in four key areas currently lacking in the industry.

  • Keen understanding of regulatory issues.

  • Institutional operating team with domain expertise.

  • Established and proven network for sourcing deals.

  • Professional investment background.

 

MedMen Opportunity Fund I

Capital 2x

Legal cannabis sales could reach $50 billion a year by 2026, according to Wall Street analyst Cowen and Company